BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23725709)

  • 21. [Thermal ablation of malignant lung tumours].
    Schneider T
    Zentralbl Chir; 2015 Feb; 140(1):104-8. PubMed ID: 25329865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and treatment of high-risk patients with early-stage lung cancer.
    Mehta HJ; Ross C; Silvestri GA; Decker RH
    Clin Chest Med; 2011 Dec; 32(4):783-97. PubMed ID: 22054886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical review of nonsurgical treatment options for stage I non-small cell lung cancer.
    Haasbeek CJ; Senan S; Smit EF; Paul MA; Slotman BJ; Lagerwaard FJ
    Oncologist; 2008 Mar; 13(3):309-19. PubMed ID: 18378542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis.
    Louie AV; Rodrigues G; Hannouf M; Zaric GS; Palma DA; Cao JQ; Yaremko BP; Malthaner R; Mocanu JD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):964-73. PubMed ID: 20932688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery versus SABR for NSCLC.
    Louie AV; Senthi S; Palma DA
    Lancet Oncol; 2013 Nov; 14(12):e491. PubMed ID: 24176567
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgery versus SABR for NSCLC.
    Moghanaki D; Karas T
    Lancet Oncol; 2013 Nov; 14(12):e490-1. PubMed ID: 24176566
    [No Abstract]   [Full Text] [Related]  

  • 27. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
    Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A brief report on outcomes of stereotactic ablative radiotherapy for a second primary lung cancer: evidence in support of routine CT surveillance.
    Griffioen GH; Lagerwaard FJ; Haasbeek CJ; Slotman BJ; Senan S
    J Thorac Oncol; 2014 Aug; 9(8):1222-5. PubMed ID: 25157777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
    Sher DJ; Wee JO; Punglia RS
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Approaching the high-risk patient: sublobar resection, stereotactic body radiation therapy, or radiofrequency ablation.
    Fernando HC; Schuchert M; Landreneau R; Daly BT
    Ann Thorac Surg; 2010 Jun; 89(6):S2123-7. PubMed ID: 20493995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotactic ablative radiation therapy for primary lung tumors.
    Heinzerling JH; Kavanagh B; Timmerman RD
    Cancer J; 2011; 17(1):28-32. PubMed ID: 21263264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgery or radiotherapy for early-stage lung cancer--a potential comparison bias.
    Van Schil PE; Van Meerbeeck J
    Lancet Oncol; 2013 Sep; 14(10):e390. PubMed ID: 23993383
    [No Abstract]   [Full Text] [Related]  

  • 33. Salvage stereotactic ablative irradiation for isolated postsurgical local recurrence of lung cancer.
    Takeda A; Sanuki N; Eriguchi T; Enomoto T; Yokosuka T; Kaneko T; Handa H; Aoki Y; Oku Y; Kunieda E
    Ann Thorac Surg; 2013 Nov; 96(5):1776-82. PubMed ID: 23998410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited surgery and radiofrequency ablation for recurrent lung cancer.
    Fukuse T; Ogawa E; Chen F; Sakai H; Wada H
    Ann Thorac Surg; 2006 Oct; 82(4):1506-8. PubMed ID: 16996966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
    Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
    Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New therapeutic approaches for early stage non-small cell lung cancer.
    El-Sherif A; Luketich JD; Landreneau RJ; Fernando HC
    Surg Oncol; 2005 Jul; 14(1):27-32. PubMed ID: 15777887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
    Takeda A; Sanuki N; Eriguchi T; Kaneko T; Morita S; Handa H; Aoki Y; Oku Y; Kunieda E
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):257-63. PubMed ID: 23570699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
    Zemlyak A; Moore WH; Bilfinger TV
    J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The present status of surgery for lung cancer.
    Lacquet LK
    Acta Chir Belg; 1996; 96(6):245-51. PubMed ID: 9008764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.